Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VERU - Veru granted expedited Australian regulatory pathway for COVID-19 treatment


VERU - Veru granted expedited Australian regulatory pathway for COVID-19 treatment

  • The Australian Therapeutic Goods Administration (TGA) had determined that Veru's ( NASDAQ: VERU ) sabizabulin treatment in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome qualifies for an expedited, provisional registration regulatory pathway.
  • ( VERU ) stock rose ~4% premarket.
  • if the application is authorized, it would allow the drug to be prescribed in Australia earlier than the standard registration process.
  • Veru’s regulatory agent in Australia is Adjutor Healthcare.

For further details see:

Veru granted expedited Australian regulatory pathway for COVID-19 treatment
Stock Information

Company Name: Veru Inc.
Stock Symbol: VERU
Market: NASDAQ
Website: verupharma.com

Menu

VERU VERU Quote VERU Short VERU News VERU Articles VERU Message Board
Get VERU Alerts

News, Short Squeeze, Breakout and More Instantly...